SK Biopharm Inks License Deal with Hikma’s Middle East Unit

SEOUL, Aug. 18 (Korea Bizwire) – SK Biopharmaceuticals Co., a pharmaceutical affiliate of South Korea’s SK Group, said Friday it has reached a license and commercialization deal with the Middle East unit of British drugmaker Hikma Pharmaceuticals Plc. Under the deal, Hikma MENA FZE is granted an exclusive license to develop and commercialize the Korean [...]